THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Grant Skrepnek to United States

This is a "connection" page, showing publications Grant Skrepnek has written about United States.
Connection Strength

2.107
  1. Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation. Adv Ther. 2023 Jan; 40(1):349-366.
    View in: PubMed
    Score: 0.134
  2. Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia. Curr Med Res Opin. 2022 Sep; 38(9):1621-1630.
    View in: PubMed
    Score: 0.131
  3. A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings. Alzheimer Dis Assoc Disord. 2022 Jul-Sep 01; 36(3):230-237.
    View in: PubMed
    Score: 0.130
  4. Clinical and economic outcomes associated with hospitalizations for acute idiopathic pericarditis in the United States. Heart Lung. 2021 Nov-Dec; 50(6):825-831.
    View in: PubMed
    Score: 0.122
  5. Hepatitis C Direct-Acting Antiviral Treatment Selection, Treatment Failure, and Use of Drug-Drug Interactions in a State Medicaid Program. J Manag Care Spec Pharm. 2019 Nov; 25(11):1261-1267.
    View in: PubMed
    Score: 0.108
  6. National estimates of case-mix, mortality, and economic outcomes among inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the US. J Eval Clin Pract. 2019 Oct; 25(5):806-821.
    View in: PubMed
    Score: 0.102
  7. Assessment of the effect of an enhanced prior authorization and management program in a United States Medicaid program on chronic hepatitis C treatment adherence and cost. J Am Pharm Assoc (2003). 2018 Sep - Oct; 58(5):485-491.
    View in: PubMed
    Score: 0.099
  8. Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid. J Manag Care Spec Pharm. 2018 Jul; 24(7):664-676.
    View in: PubMed
    Score: 0.099
  9. Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer. Am J Med. 2018 10; 131(10):1187-1199.e5.
    View in: PubMed
    Score: 0.099
  10. Health Care Service and Outcomes Among an Estimated 6.7 Million Ambulatory Care Diabetic Foot Cases in the U.S. Diabetes Care. 2017 07; 40(7):936-942.
    View in: PubMed
    Score: 0.091
  11. Clinical and economic characteristics of emergency department visits due to acetaminophen toxicity in the USA. BMJ Open. 2015 Sep 09; 5(9):e007368.
    View in: PubMed
    Score: 0.081
  12. A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010. PLoS One. 2015; 10(8):e0134914.
    View in: PubMed
    Score: 0.081
  13. Emergency department visits in the United States for pediatric depression: estimates of charges and hospitalization. Acad Emerg Med. 2014 Sep; 21(9):1003-14.
    View in: PubMed
    Score: 0.076
  14. Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010. J Vasc Surg. 2014 Nov; 60(5):1255-1265.
    View in: PubMed
    Score: 0.075
  15. Clinical and economic burden of Richter syndrome in inpatient cases of chronic lymphocytic leukemia within the United States, 2001-2010. Leuk Lymphoma. 2014 Apr; 55(4):834-40.
    View in: PubMed
    Score: 0.070
  16. Health care expenditures, hospitalizations, and productivity associated with cancer in US employer settings. J Occup Environ Med. 2012 Dec; 54(12):1453-60.
    View in: PubMed
    Score: 0.067
  17. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012 Apr; 9(2):131-41.
    View in: PubMed
    Score: 0.064
  18. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S. Gen Dent. 2010 Nov-Dec; 58(6):484-92; quiz 493-4.
    View in: PubMed
    Score: 0.058
  19. The cost-effectiveness of sertraline in the treatment of depression. Expert Opin Pharmacother. 2008 Oct; 9(14):2497-508.
    View in: PubMed
    Score: 0.050
  20. Relationship between pharmaceutical services characteristics and exposure rates to drug-drug interactions in Veterans Affairs medical centers. Am J Health Syst Pharm. 2008 Sep 15; 65(18):1744-9.
    View in: PubMed
    Score: 0.050
  21. Workload and availability of technology in metropolitan community pharmacies. J Am Pharm Assoc (2003). 2006 Mar-Apr; 46(2):154-60.
    View in: PubMed
    Score: 0.042
  22. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am J Manag Care. 2004 Jul; 10(5 Suppl):S129-38.
    View in: PubMed
    Score: 0.037
  23. Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study. Clin Microbiol Infect. 2019 Aug; 25(8):987-993.
    View in: PubMed
    Score: 0.026
  24. Sleep-Disordered Breathing is Associated With Increased Mortality in Hospitalized Infants With Congenital Heart Disease. J Clin Sleep Med. 2018 09 15; 14(9):1551-1558.
    View in: PubMed
    Score: 0.025
  25. State Medicaid Programs Bring Managed Care Tenets to Fee for Service. J Manag Care Spec Pharm. 2016 Feb; 22(2):145-8.
    View in: PubMed
    Score: 0.021
  26. Administration of first dose antibiotic in the ED in patients with minor skin and soft tissue infections. Am J Emerg Med. 2015 Sep; 33(9):1225-8.
    View in: PubMed
    Score: 0.020
  27. Is scorpion antivenom cost-effective as marketed in the United States? Toxicon. 2013 Dec 15; 76:394-8.
    View in: PubMed
    Score: 0.018
  28. Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies. J Manag Care Pharm. 2013 Jan-Feb; 19(1 Suppl A):S41-53.
    View in: PubMed
    Score: 0.017
  29. Effect of epidural analgesia on postoperative complications following pancreaticoduodenectomy. Am J Surg. 2012 Dec; 204(6):1000-4; discussion 1004-6.
    View in: PubMed
    Score: 0.017
  30. Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs. J Med Econ. 2013; 16(1):10-8.
    View in: PubMed
    Score: 0.017
  31. Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug Saf. 2008; 31(6):525-36.
    View in: PubMed
    Score: 0.012
  32. Reasons provided by prescribers when overriding drug-drug interaction alerts. Am J Manag Care. 2007 Oct; 13(10):573-8.
    View in: PubMed
    Score: 0.012
  33. Potential drug-drug interactions within Veterans Affairs medical centers. Am J Health Syst Pharm. 2007 Jul 15; 64(14):1500-5.
    View in: PubMed
    Score: 0.012
  34. Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System. Pharmacotherapy. 2007 Jun; 27(6):813-24.
    View in: PubMed
    Score: 0.011
  35. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions. Med Care. 2007 May; 45(5):456-62.
    View in: PubMed
    Score: 0.011
  36. A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer. Int J Gynecol Cancer. 2007 May-Jun; 17(3):561-70.
    View in: PubMed
    Score: 0.011
  37. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007 Jan-Feb; 20(1):72-80.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES